Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Soleno Therapeutics, Inc. (SLNO : NSDQ)

• Company Description    Soleno Therapeutics Inc. is a healthcare company. It develops and commercializes diagnostics, devices and therapeutics addressing unmet medical needs. The Company offers products consists of CoSense end-tidal carbon monoxide Monitor, NeoPIP Infant Resuscitator and Accessories and Serenz Nasal Relief. Soleno Therapeutics Inc., formerly known as Capnia Inc., is based in Vancouver, Canada. Number of Employees: 92

• Price / Volume Information    Yesterday's Closing Price: $46.30 Daily Weekly Monthly 20 Day Moving Average: 1,161,436 shares Shares Outstanding: 53.71 (millions) Market Capitalization: $2,486.77 (millions) Beta: -3.12 52 Week High: $90.32 52 Week Low: $41.50 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -12.11% -11.96% 12 Week -29.38% -30.52% Year To Date 0.00% 0.00%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 100 MARINE PARKWAY SUITE 400 - REDWOOD CITY,CA 94065 USA ph: 650-213-8444 fax: 650-213-8383 info@soleno.life http://www.soleno.life

• General Corporate Information    Officers Anish Bhatnagar - President; Chief Executive Officer and Director James Mackaness - Chief Financial Officer Matthew Pauls - Lead Independent Director Andrew Sinclair - Director William G. Harris - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-DRUGS Sector: Medical CUSIP: 834203309 SIC: 3845 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/25 Next Expected EPS Date: 02/26/26 Share - Related Items Shares Outstanding: 53.71 Most Recent Split Date: 8.00 (0.07:1) Beta: -3.12 Market Capitalization: $2,486.77 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.65 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $3.59 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 7.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 02/26/26

• Fundamental Ratios P/E Current FY Estimate: 12.91 Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 4.97 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: 125.68% vs. Previous Quarter: 622.22% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: 102.16% ROE 12/31/25 - - 09/30/25 - -25.88 06/30/25 - -73.74 ROA 12/31/25 - - 09/30/25 - -19.84 06/30/25 - -56.67 Current Ratio 12/31/25 - - 09/30/25 - 16.08 06/30/25 - 15.13 Quick Ratio 12/31/25 - - 09/30/25 - 15.88 06/30/25 - 15.01 Operating Margin 12/31/25 - - 09/30/25 - - 06/30/25 - - Net Margin 12/31/25 - - 09/30/25 - - 06/30/25 - - Pre-Tax Margin 12/31/25 - - 09/30/25 - -79.50 06/30/25 - -554.49 Book Value 12/31/25 - - 09/30/25 - 9.31 06/30/25 - 4.77 Inventory Turnover 12/31/25 - - 09/30/25 - 0.81 06/30/25 - 1.18 Debt-to-Equity 12/31/25 - - 09/30/25 - 0.10 06/30/25 - 0.21 Debt-to-Capital 12/31/25 - - 09/30/25 - 9.15 06/30/25 - 17.19

Powered by Zacks Investment Research ©